Navigation Links
Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute
Date:1/28/2008

immune response to cancer vaccination and establishing surrogate biological markers for therapeutic benefits;
  • Managing the production and acquisition of reagents for clinical trials of cancer vaccines;
  • Continuing support of the existing international network of academic laboratory and clinical investigators conducting early-phase cancer vaccine trials aimed at learning how to effectively immunize against cancer.

    Lloyd J. Old, M.D., chairman of the Ludwig Institute for Cancer Research, director of the Cancer Research Institute Scientific Advisory Council, and director of the CRI/LICR Cancer Vaccine Collaborative, will also serve as director of the CRI Cancer Vaccine Consortium and chairman of its Executive Committee. Axel Hoos, M.D., Ph.D., medical lead in Immuno-Oncology at Bristol-Myers Squibb Company and former president of the Sabin Vaccine Institutes Cancer Vaccine Consortium, will serve as co-chairman of the Cancer Vaccine Consortium Executive Committee.

    The time is ripe for stronger alliances between academia and industry, says Dr. Old. Integrating the clinical trials network of the CRI/LICR Cancer Vaccine Collaborative with the strengths of the pharmaceutical, biotech, and academic membership of the Sabin Cancer Vaccine Consortium will allow the Cancer Research Institute to present a single, united front on cancer vaccines to the scientific and medical communities. This alignment strengthens the overall position of all of its participants and establishes a unified voice that can represent the needs of a broader constituency.

    Dr. Hoos anticipates that the joint effort will play a key role in facilitating knowledge exchange and creating a fertile environment for advances in cancer immunotherapy. The Sabin Vaccine Institutes Cancer Vaccine Consortium had very successfully begun to address issues of clinical paradigm development, immune assay harmonization, and regulatory dialogue, Dr. Hoos says. Based on the Consortiu
    '/>"/>


    • Contact: Brian Brewer
    bbrewer@cancerresearch.org
    212-688-7515
    Cancer Research Institute
    Source:Eurekalert

    0

    GOOD

    Page: 1 2 3

    Related medicine news :

    1. Teens, Young Adults Missing Out on Latest Cancer Advances
    2. Oral Contraceptives Cut Ovarian Cancer Risk
    3. TNF-alpha antagonist stops inflammation-induced colon cancer in its tracks
    4. New Colon Cancer Test Might Spot Trouble Earlier
    5. Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute
    6. Synthesis of natural molecule could lead to better anti-cancer drugs
    7. Engineers use bloods hydrodynamics to manipulate stem, cancer cells
    8. Combination therapy improves survival for certain prostate cancer patients
    9. Hormone Therapy Only Helps Some Older Men With Prostate Cancer
    10. Cell division studies hint at future cancer therapy
    11. Regular, long-term aspirin use reduces risk of colorectal cancer

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/23/2009)...ewswire/--James.G.Schwade,M.D.announcesthenewlyenh...attheCyberKnifeCenterofMiami,( www.cyberknifemiam...preciselytargetedintensedoseofradiationthatkillsca...fthetreatmentcanlastfrom30minutestoonehour,andisus...erKnifeTreatmentCenterintheSoutheasternU.S.,theMia...
    (Date:11/23/2009)...fected within one year of starting to have sex, CD...hDay News) -- As many as one in four U.S. teenage ...), many infected soon after their first sexual enc...igh burden of STDs among teen girls reminds us tha...i L. Gottlieb, from the division of sexually trans...
    (Date:11/23/2009)...ical College of Georgia is leading an initiative t...f patients with sickle cell disease. , Morehous...Florida are partners in the initiative that is enl...erve as "medical homes" for patients, changing how...m to the hospital and seeking better prevention an...
    (Date:11/23/2009)...3/PRNewswire-FirstCall/--InstacareCorp.(OTCBulleti...of MD@Hand ,target=,_blank,title=, MD@Hand ,> MD@H...nk,title=, MD@Hand ,> MD@Hand ,> MD@Hand ,target=...nk,title=, MD@Hand ,target=,_blank,title=, MD@Hand...et=,_blank,title=, MD@Hand ,> MD@Hand ,> MD@Hand ...
    (Date:11/23/2009)...3/PRNewswire/--Thanksgivingweekendmarksthe36thannu...,theClassicrepresentsthesportsmanshipandprideoftwo...leansandthoseinattendance. ,, Forthecrewofthene...omedowntimebeforetheyworktotestandlaunchabrandnews...uction,PettyOfficerClaudeBovellandtherestofthecrew...
    Breaking Medicine News(10 mins):Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 4Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 6Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 7Health News:Nothing Is Like Being There 2
    ...EXICO CITY, Feb. 17 Genomma Lab Internacional,S.A...cast: , , WHAT: Genomma Lab,s Fourth Quarte...bruary 18, 2009 at 11:00 A.M. Eastern, WHERE: ...., CONTACT: Melanie Carpenter, 212-406-3692, ...
    ...UBLIN, Ohio, Feb. 17 Cardinal Health today,announ...g Administration (FDA),on an amended consent decre..., Cardinal Health has operated under a consent...ended agreement, which is subject,to approval by t...
    ...y Olympic sport, Rodriguez would be banned at leas...Alex Rodriguez and Major League Baseball are showi... abuse," asserts former White House Drug Policy sp...rug Policy spokesman 1995-2001 and coordinated Whi...
    ...ical teams at The Johns Hopkins Hospital, Barnes-J...edical Center in Oklahoma City successfully comple...ino kidney transplant. All six donors one man and...rgeon at Johns Hopkins. , The procedure, kidney p...
    ... University,s Baker Institute has experts availabl...embryonic stem cell policy. , In January, Baker ...eleased policy recommendations on stem cell resear...a federal stem cell policy be developed. They enco...
    ... - Results demonstrate that GCC is the stronge...ectal cancer recurrence -, Ticker Symbol: CUR, ... /PRNewswire-FirstCall/ - The Journal of the Ameri...led patients demonstrating that guanylyl cyclase C...
    Other Medicine News:Health News:Cardinal Health, FDA Amend Infusion Pump Consent Decree 2Health News:Rodriguez and Baseball: 'No Accountability'; 'Disgraceful' News Conference, Says Ex-White House Drug Spokesman Robert Weiner 2Health News:Johns Hopkins leads first 12-patient, multicenter 'domino donor' kidney transplant 2Health News:Major study on DiagnoCure's GCC biomarker published in Jama 2Health News:Major study on DiagnoCure's GCC biomarker published in Jama 3Health News:Major study on DiagnoCure's GCC biomarker published in Jama 4
    (Date:11/23/2009)...Calif.,Nov.23/PRNewswire-FirstCall/--Neurobiologic...todaythatitsboardofdirectorshasdeclaredanextraordi...bepaidonDecember9,2009tostockholdersofrecordasofNo...ndfollowsstockholderapprovalofthedissolutionofNTIp...ndanearlierextraordinarydividendof$0.75persharetha...
    (Date:11/21/2009)...N, Nov. 21 An urgent need for new ...n the developing world has prompted a growing numb...on-profit product development partnerships (PDPs),...s noted today in a symposium at the 58th annual me... and Hygiene (ASTMH), these collaborations are ope...
    (Date:11/20/2009)...la., Nov. 20 Unilens Vis...xchange: UVI), which develops, licenses, manufactu...ses, today reported its operating results for the ..., Net sales excluding royalty income, were $1,6... $1,761,526 reported in the previous year first qu...
    Breaking Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Anesthesia Society Selects Sanford Brown Institute Instructor as Educator of the Year 61187 1Anesthesia Society Selects Sanford Brown Institute Instructor as Educator of the Year 61187 2Anesthesia Society Selects Sanford Brown Institute Instructor as Educator of the Year 61187 3Surgery Not Always Best for Narrowed Kidney Arteries 61185 1Surgery Not Always Best for Narrowed Kidney Arteries 61185 2Surgery Not Always Best for Narrowed Kidney Arteries 61185 3Tamiflu Resistant Swine Flu Found in Canadian Father 61183 1Tamiflu Resistant Swine Flu Found in Canadian Father 61183 2Tamiflu Resistant Swine Flu Found in Canadian Father 61183 3
    ... /PRNewswire-FirstCall/ --,Medivation, Inc. today ...30 a.m. Eastern time on Monday, June 11, to discus...ouble-blind,placebo-controlled Phase 2 clinical t...n Alzheimer,s disease. , Rachelle Doody, M.D., Ph....the 12-month results for the first time at a,scien...
    ... 7, 2007 - Clinical results from a,Phase II study ...che Society (AHS) annual meeting showed that MK-09...d peptide (CGRP),receptor antagonist, significantl...sing compared to placebo, and the relief was,susta...tolerated in,the study. Responses specific to othe...
    Other Medicine Technology:Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 2Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5
    Lasik Irrigator
    Lasik Cannula - Daya
    Anterior Chamber Maintainer
    Irrigating Cannula - Rycroft
    Medicine Products: